-
China takes action to combat rise of acute respiratory infections
2023-11-28
China is taking measures to address the recent increase in acute respiratory infections caused by different respiratory pathogens as the country enters the winter season.
-
Efforts underway to curb nationwide flu outbreaks among children
2023-11-28
China is reinforcing its grassroots facilities to cope with the outbreak of seasonal respiratory illnesses among children, in a bid to ease the pressure on major hospitals at this time.
-
Nation aims to improve cancer survival rates
2023-11-20
China aims to raise the overall five-year survival rate for cancers to over 46.6 percent by 2030 by rolling out comprehensive measures including promoting healthy lifestyles, expanding screening and accelerating the development of new technologies, officials and experts said on Wednesday.
-
China releases work plan for curbing heart and brain diseases
2023-11-20
Chinese health authorities have recently released a work plan on the prevention and treatment of cardio-cerebrovascular diseases.
-
Quick review of 2022 Drug Review Annual Report
2023-11-14
In 2022, the NMPA reviewed and recommended the approval of 21 innovative drugs, including 3 first-in-class drugs.
-
NMPA becomes the applicant for PIC/S
2023-11-09
In late September 2023, the National Medical Products Administration (NMPA) submitted the formal application to the Pharmaceutical Inspection Co-operation Scheme (PIC/S). On Nov 8, 2023, PIC/S sent a letter to NMPA confirming the applicant status.
